APPROVED AND EMERGING OPTIONS FOR ONCOLOGY TREATMENT-RELATED TOXICITIES: A TARGETED LITERATURE REVIEW OF THE LANDSCAPE AND REMAINING UNMET NEEDS

Kepivance (palifermin) - SOBI, Amgen

amifostine - Generic mfg.

avasopasem (GC4419) - Biossil

Cosela (trilaciclib) - Pharmacosmos

dexrazoxane - Generic mfg.

mesna - Generic mfg.

uridine triacetate (PN 401) - Wellstat

leucovorin calcium - Generic mfg.

Actemra IV (tocilizumab) - Roche, JW Pharma

cisplatin - Generic mfg.

methotrexate IV - Generic mfg.

Setareh A. Williams, PhD 1; Richard J. Weiss, MD 2; Charles D. Williams, BS 1; Ted W. Everson, PhD 3

Mar 6, 2026